Related references
Note: Only part of the references are listed.Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies
Jian Li et al.
MOLECULES (2010)
Re-educating tumor-associated macrophages by targeting NF-κB
Thorsten Hagemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Colonization and infection by Helicobacter pylori in humans
Leif Percival Andersen
HELICOBACTER (2007)
Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells
Jun Wang et al.
PHARMACOLOGY (2007)
Inhibition of Helicobacter pylori and associated urease by oregano and cranberry phytochemical synergies
YT Lin et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy
S Datta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Antibacterial effect of plant extracts against Helicobacter pylori
A Nostro et al.
PHYTOTHERAPY RESEARCH (2005)
Helicobacter pylori eradication has the potential to prevent gastric cancer: A state-of-the-art critique
P Malfertheiner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents
M Jung et al.
CURRENT MEDICINAL CHEMISTRY (2004)
ADME evaluation in drug discovery. 4. Prediction of aqueous solubility based on atom contribution approach
TJ Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori
K Funatogawa et al.
MICROBIOLOGY AND IMMUNOLOGY (2004)
A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro
Y Yanagawa et al.
CURRENT MICROBIOLOGY (2003)
Gastric transitional zones, areas where Helicobacter treatment fails:: Results of a treatment trial using the Sydney strain mouse model
SJOV van Zanten et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo
T Koga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Helicobacter pylori susceptibility testing by disc diffusion
C McNulty et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin:: synthesis and in vitro antimalarial activity of new, metabolically stable C-10 analogues
PM O'Neill et al.
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1 (2001)
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection
T Kanamaru et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Helicobacter pylori:: Current chemotherapy and new targets for drug design
JS Williamson
CURRENT PHARMACEUTICAL DESIGN (2001)
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori
DH Kwon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Antibiotic-resistant H-pylori infection and its treatment
WA Qureshi et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil
S Mendonça et al.
HELICOBACTER (2000)
Share Paper
